PubMed HealthSearch

Biomedical subjects

H Müther

Publications and source records attributed to H Müther.

3 recordsLinked to original sources

Intermolecular cystine-bonding of murine interleukin 2 indicates that ligand dimerization is important for the formation of the high-affinity receptor complex.

Interleukin 2 is thought to be active as a monomeric protein. As the nonessential Cys-140 of murine interleukin 2 (mIL2) is located in the hydrophobic interface of the amphiphilic F domain it was successfully used to stabilize hydrophobic amino acid contacts between two mIL2 cores yielding biologically active cystine-bonded dimeric mIL2. (3H) thymidine incorporation assays with intermolecular cystine-bonded or monomeric mIL2 revealed almost identical median effective concentrations (EC50) and high-affinity dissociation constants (Kdh), respectively. Comparative binding and internalization assays suggest that one cystine-bonded dimeric or two monomeric mIL2 molecules bind to the high-affinity receptor complex. Furthermore, DSS concentration-dependent crosslinking studies using monomeric mIL2 revealed four membrane-derived protein-complexes with apparent molecular weights of about 70 kDa, 85 kDa, 95 kDa and 100 kDa, respectively, showing that both mIL2 receptor chains may be crosslinked to a monomeric or dimeric ligand molecule, respectively. We therefore propose that dimerization of murine interleukin 2 occurring either in solution at concentrations above the low-affinity dissociation constant or at the low-affinity receptor is important for regulation of high-affinity complex formation and signal transduction.

Amino Acid Sequence

[Value of physiological coagulation parameters in perioperative consumption coagulopathy using low heparin doses].

In the course of extensive operations there are disturbances of the turnover-rate because of the activation of the clotting-system. These may equally be demonstrated by simple reproducible and quick global tests as by methods which are expensive and reserved only to special laboratories. By consequent low dosis-heparin-medication hypercoagulability-conditions and reactive hemorrhage complications are prevented and the hemostasis situation is significantly improved. No disturbance of the hemostasis by antithrombin-3-effect of the heparin-application in this dosage can be proved. The results of the examination including quality control and interpretation can be obtained in 30 minutes.

Blood Coagulation Tests